Mabion S.A. (MAB.WA)
PLN 9.49
(-4.33%)
PLN 9.49
(-4.33%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 41.26 Million PLN | 77.94% |
| 2022 | 23.19 Million PLN | 1118.71% |
| 2021 | 1.9 Million PLN | 103.33% |
| 2020 | -57.18 Million PLN | 11.62% |
| 2019 | -64.7 Million PLN | 6.04% |
| 2018 | -68.87 Million PLN | -18.97% |
| 2017 | -57.88 Million PLN | -3.69% |
| 2016 | -55.82 Million PLN | -1114.4% |
| 2015 | -4.59 Million PLN | -3.04% |
| 2014 | -4.46 Million PLN | -14.65% |
| 2013 | -3.89 Million PLN | -83.42% |
| 2012 | -2.12 Million PLN | -56.68% |
| 2011 | -1.35 Million PLN | -387.21% |
| 2010 | 471.44 Thousand PLN | 243.41% |
| 2009 | -328.75 Thousand PLN | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 10.29 Million PLN | -41.33% |
| 2024 Q3 | -16.29 Million PLN | -258.31% |
| 2024 Q1 | 17.54 Million PLN | 1449.31% |
| 2023 Q3 | 10.85 Million PLN | -28.79% |
| 2023 Q2 | 15.24 Million PLN | -7.44% |
| 2023 FY | 41.26 Million PLN | 77.94% |
| 2023 Q1 | 16.47 Million PLN | 4.95% |
| 2023 Q4 | -1.3 Million PLN | -111.97% |
| 2022 Q3 | -3.27 Million PLN | -163.97% |
| 2022 Q1 | 7.44 Million PLN | -79.94% |
| 2022 FY | 23.19 Million PLN | 1118.71% |
| 2022 Q4 | 15.69 Million PLN | 579.32% |
| 2022 Q2 | 5.11 Million PLN | -31.23% |
| 2021 FY | 1.9 Million PLN | 103.33% |
| 2021 Q4 | 37.1 Million PLN | 337.39% |
| 2021 Q1 | -17.07 Million PLN | -7.91% |
| 2021 Q3 | -15.63 Million PLN | -525.99% |
| 2021 Q2 | -2.49 Million PLN | 85.38% |
| 2020 Q1 | -19.84 Million PLN | -29.63% |
| 2020 Q4 | -15.82 Million PLN | -73.53% |
| 2020 FY | -57.18 Million PLN | 11.62% |
| 2020 Q3 | -9.11 Million PLN | 16.97% |
| 2020 Q2 | -10.98 Million PLN | 44.66% |
| 2019 Q4 | -15.3 Million PLN | 8.51% |
| 2019 FY | -64.7 Million PLN | 6.04% |
| 2019 Q1 | -14.98 Million PLN | 9.64% |
| 2019 Q2 | -16.71 Million PLN | -11.52% |
| 2019 Q3 | -16.73 Million PLN | -0.13% |
| 2018 Q1 | -14.34 Million PLN | 25.6% |
| 2018 FY | -68.87 Million PLN | -18.97% |
| 2018 Q3 | -11.1 Million PLN | 58.62% |
| 2018 Q2 | -26.83 Million PLN | -87.0% |
| 2018 Q4 | -16.58 Million PLN | -49.35% |
| 2017 Q4 | -19.28 Million PLN | -45.77% |
| 2017 Q3 | -13.23 Million PLN | -5.7% |
| 2017 Q2 | -12.51 Million PLN | 2.59% |
| 2017 Q1 | -12.85 Million PLN | 73.93% |
| 2017 FY | -57.88 Million PLN | -3.69% |
| 2016 Q2 | -13.84 Million PLN | -552.71% |
| 2016 Q1 | -2.12 Million PLN | -676.92% |
| 2016 FY | -55.82 Million PLN | -1114.4% |
| 2016 Q4 | -49.3 Million PLN | -2504.44% |
| 2016 Q3 | -1.89 Million PLN | 86.33% |
| 2015 Q1 | -1.39 Million PLN | 8.64% |
| 2015 Q2 | -589.62 Thousand PLN | 57.82% |
| 2015 FY | -4.59 Million PLN | -3.04% |
| 2015 Q4 | -273 Thousand PLN | 88.31% |
| 2015 Q3 | -2.33 Million PLN | -296.19% |
| 2014 FY | -4.46 Million PLN | -14.65% |
| 2014 Q4 | -1.53 Million PLN | -31.35% |
| 2014 Q3 | -1.16 Million PLN | -9.49% |
| 2014 Q2 | -1.06 Million PLN | -51.57% |
| 2014 Q1 | -702 Thousand PLN | 52.12% |
| 2013 Q1 | -336 Thousand PLN | 68.38% |
| 2013 Q3 | -853 Thousand PLN | 30.99% |
| 2013 Q4 | -1.46 Million PLN | -71.89% |
| 2013 Q2 | -1.23 Million PLN | -267.86% |
| 2013 FY | -3.89 Million PLN | -83.42% |
| 2012 Q2 | -499 Thousand PLN | -87.59% |
| 2012 Q4 | -1.06 Million PLN | -261.38% |
| 2012 FY | -2.12 Million PLN | -56.68% |
| 2012 Q1 | -266 Thousand PLN | 0.0% |
| 2012 Q3 | -294 Thousand PLN | 41.08% |
| 2011 FY | -1.35 Million PLN | -387.21% |
| 2010 FY | 471.44 Thousand PLN | 243.41% |
| 2009 FY | -328.75 Thousand PLN | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bioceltix S.A. | -13.68 Million PLN | 401.508% |
| BIOTON S.A. | 2.27 Million PLN | -1714.022% |
| Captor Therapeutics Spolka Akcyjna | -70.58 Million PLN | 158.468% |
| Molecure S.A. | -18.3 Million PLN | 325.413% |
| NanoGroup S.A. | -7.88 Million PLN | 623.066% |
| Pharmena S.A. | 28.94 Million PLN | -42.597% |
| Poltreg S.A. | -13.55 Million PLN | 404.546% |
| Pure Biologics Spólka Akcyjna | -35.69 Million PLN | 215.619% |
| Ryvu Therapeutics S.A. | -92.11 Million PLN | 144.803% |
| Synthaverse S.A. | 4.75 Million PLN | -767.36% |
| Urteste S.A. | -5.58 Million PLN | 838.793% |